144 related articles for article (PubMed ID: 37898882)
1. [The molecular genetic aspects of basal cell carcinoma from the position of population health preservation].
Khabriev RU; Sadykova RN; Mingazova EN; Bespyatykh JA
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Sep; 31(5):946-950. PubMed ID: 37898882
[TBL] [Abstract][Full Text] [Related]
2. Patched-2 functions to limit Patched-1 deficient skin cancer growth.
Veenstra VL; Dingjan I; Waasdorp C; Damhofer H; van der Wal AC; van Laarhoven HW; Medema JP; Bijlsma MF
Cell Oncol (Dordr); 2018 Aug; 41(4):427-437. PubMed ID: 29869097
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.
Tang JY; Aszterbaum M; Athar M; Barsanti F; Cappola C; Estevez N; Hebert J; Hwang J; Khaimskiy Y; Kim A; Lu Y; So PL; Tang X; Kohn MA; McCulloch CE; Kopelovich L; Bickers DR; Epstein EH
Cancer Prev Res (Phila); 2010 Jan; 3(1):25-34. PubMed ID: 20051370
[TBL] [Abstract][Full Text] [Related]
4. Novel alterations in IFT172 and KIFAP3 may induce basal cell carcinoma.
Onodera S; Morita N; Nakamura Y; Takahashi S; Hashimoto K; Nomura T; Katakura A; Kosaki K; Azuma T
Orphanet J Rare Dis; 2021 Oct; 16(1):443. PubMed ID: 34674729
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma.
Russell-Goldman E; MacConaill L; Hanna J
Am J Dermatopathol; 2021 Apr; 43(4):266-272. PubMed ID: 32796174
[TBL] [Abstract][Full Text] [Related]
6. Genetics of basal cell carcinoma.
de Zwaan SE; Haass NK
Australas J Dermatol; 2010 May; 51(2):81-92; quiz 93-4. PubMed ID: 20546211
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures.
Brellier F; Bergoglio V; Valin A; Barnay S; Chevallier-Lagente O; Vielh P; Spatz A; Gorry P; Avril MF; Magnaldo T
Oncogene; 2008 Nov; 27(51):6601-6. PubMed ID: 18679421
[TBL] [Abstract][Full Text] [Related]
8. Topical tazarotene chemoprevention reduces Basal cell carcinoma number and size in Ptch1+/- mice exposed to ultraviolet or ionizing radiation.
So PL; Lee K; Hebert J; Walker P; Lu Y; Hwang J; Kopelovich L; Athar M; Bickers D; Aszterbaum M; Epstein EH
Cancer Res; 2004 Jul; 64(13):4385-9. PubMed ID: 15231643
[TBL] [Abstract][Full Text] [Related]
9. Spreading of Isolated
Brandes N; Mitkovska SH; Botermann DS; Maurer W; Müllen A; Scheile H; Zabel S; Frommhold A; Heß I; Hahn H; Uhmann A
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291515
[TBL] [Abstract][Full Text] [Related]
10. Nevoid Basal Cell Carcinoma Syndrome:
Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanisms and Targeted Therapies of Advanced Basal Cell Carcinoma.
Hoashi T; Kanda N; Saeki H
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233269
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Hereditary Basal Cell Skin Cancer.
Shanley S; McCormack C
Recent Results Cancer Res; 2016; 205():191-212. PubMed ID: 27075355
[TBL] [Abstract][Full Text] [Related]
13. PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.
Santos DC; Zaphiropoulos PG; Neto CF; Pimentel ER; Sanches JA; Ruiz IR
Int J Dermatol; 2011 Jul; 50(7):838-43. PubMed ID: 21699520
[TBL] [Abstract][Full Text] [Related]
14. A novel splicing mutation of PTCH1 in a Chinese family with nevoid basal cell carcinoma syndrome.
Zhou J; Zhang G; Shi M; Liu Z; Xiao M; Fu S; Gong X; Shi X
Med Mol Morphol; 2019 Dec; 52(4):235-237. PubMed ID: 30997576
[TBL] [Abstract][Full Text] [Related]
15. Basal cell nevus syndrome: clinical and molecular review and case report.
Pino LC; Balassiano LK; Sessim M; de Almeida AP; Empinotti VD; Semenovitch I; Treu C; Lupi O
Int J Dermatol; 2016 Apr; 55(4):367-75. PubMed ID: 26356331
[TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of SOX18 in Basal cell carcinoma negatively regulates tumour progression.
Villani R; Sim SL; Roy E; Wainwright B; Francois M; Khosrotehrani K
J Dermatol Sci; 2020 Jun; 98(3):179-185. PubMed ID: 32444239
[TBL] [Abstract][Full Text] [Related]
17. Morphologic, Immunohistochemical, and Molecular Distinction Between Fibroepithelioma of Pinkus and "Fenestrated" Basal Cell Carcinoma.
Russell-Goldman E; Lindeman NI; Laga AC; Hanna J
Am J Dermatopathol; 2020 Jul; 42(7):513-520. PubMed ID: 31693503
[TBL] [Abstract][Full Text] [Related]
18. Activating Smoothened mutations in sporadic basal-cell carcinoma.
Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH; de Sauvage FJ
Nature; 1998 Jan; 391(6662):90-2. PubMed ID: 9422511
[TBL] [Abstract][Full Text] [Related]
19. Linear basal cell nevus with a novel mosaic PTCH1 mutation.
Saeidian AH; Cohen-Nowak A; O'Donnell M; Shalabi D; McGuinn KP; Youssefian L; Vahidnezhad H; Niaziorimi F; Dasgeb B; Kasper DA; Lee JB; Uitto J; Nikbakht N
Exp Dermatol; 2020 Jun; 29(6):531-534. PubMed ID: 32298489
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms.
Lacour JP
Br J Dermatol; 2002 Apr; 146 Suppl 61():17-9. PubMed ID: 11966727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
